Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neuroprotective effects of bee venom phospholipase A2 in the 3xTg AD mouse model of Alzheimer’s disease ; volume:13 ; number:1 ; day:16 ; month:1 ; year:2016 ; pages:1-12 ; date:12.2016
Journal of neuroinflammation ; 13, Heft 1 (16.1.2016), 1-12, 12.2016
- Creator
-
Ye, Minsook
Chung, Hwan-Suck
Lee, Chanju
Yoon, Moon Sik
Yu, A. Ram
Kim, Jin Su
Hwang, Deok-Sang
Shim, Insop
Bae, Hyunsu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12974-016-0476-z
- URN
-
urn:nbn:de:101:1-2019080820322440926680
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Ye, Minsook
- Chung, Hwan-Suck
- Lee, Chanju
- Yoon, Moon Sik
- Yu, A. Ram
- Kim, Jin Su
- Hwang, Deok-Sang
- Shim, Insop
- Bae, Hyunsu
- SpringerLink (Online service)
Other Objects (12)
Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
Neuroprotective Effects of IVIG against Alzheimer’s Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer’s disease in 3xTg mice
Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
Neuroprotective Effects of IVIG against Alzheimer’s Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer’s disease in 3xTg mice
Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease
Molecular characterization of neuroprotective β-amyloid interacting peptides and autoantibodies relevant to Alzheimer’s disease
Bee venom phospholipase A2 ameliorates Alzheimer’s disease pathology in Aβ vaccination treatment without inducing neuro-inflammation in a 3xTg-AD mouse model
Enhancing mitochondrial one-carbon metabolism is neuroprotective in Alzheimer’s disease models
Neuroprotective Effects of IVIG against Alzheimer’s Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice
Impaired Spatial Reorientation in the 3xTg-AD Mouse Model of Alzheimer’s Disease
Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis
Modifying Rap1-signalling by targeting Pde6δ is neuroprotective in models of Alzheimer’s disease
Blocking microglial activation of reactive astrocytes is neuroprotective in models of Alzheimer’s disease
A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer’s disease in 3xTg mice
Enhanced susceptibility of triple transgenic Alzheimer’s disease (3xTg-AD) mice to acute infection
Alzheimer’s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph
Biaryl scaffold-focused virtual screening for anti-aggregatory and neuroprotective effects in Alzheimer’s disease